Β-lactamases: Difference between revisions

From IDWiki
Β-lactamases
No edit summary
Line 40: Line 40:
*[[Carbapenems]], [[aminoglycosides]], [[fluoroquinolones]], and [[TMP-SMX]] typically work well
*[[Carbapenems]], [[aminoglycosides]], [[fluoroquinolones]], and [[TMP-SMX]] typically work well


{{DISPLAYTITLE:β-lactamases}}
[[Category:Antibiotics]]
[[Category:Antibiotics]]

Revision as of 12:35, 12 September 2020

Background

Classification

  • Classes A, B, and C: serine β-lactamases
    • Class A: inhibited by clavulanic acid or tazobactam
      • Constitutively expressed plasmid
      • Most common ESBL in Gram-negative bacteria
      • Resistance to 2nd and 3rd generation cephalosporins
      • Common in E. coli, Klebsiella, and Proteus spp.
      • Examples include:
        • Penicillinases: TEM-1 (common in GNBs), SHV-1
        • ESBLs: CTX-M, TEM-3
        • Carbapenemases: K. pneumoniae carbapenemase (KPC)
    • Class C: not inhibited by clavulanic acid or EDTA, resistant to cefoxitin, inhibited by clox in vitro
    • Class D: not inhibited by EDTA, variably inhibited by clavulanic acid; hard to identify
      • Common in Pseudomonas
      • Difficult to detect with routine screening
      • Examples include:
        • ESBLs: OXA-11
        • Carbapenemases: OXA-23, OXA-48
  • Class B: metallo-β-lactamase, inhibited by EDTA, not inhibited by clavulanic acid
    • Examples include:
      • Carbapenemases:
        • New Delhi metallo-beta-lactamase (NDM-1)
        • Imipenemases (IMP)
        • Verona integron-encoded metallo-β-lactamases (VIM)

Epidemiology

  • The most common β-lactamase is TEM-1
  • The most common carbapenemases in the US are KPCs, followed by NDM and OXA-48-like carbapenemases

Management

References

  1. ^  R. Cantón, M.I. Morosini, O. Martin, S. de la Maza, E. Gomez G. de la Pedrosa. IRT and CMT β-lactamases and inhibitor resistance. Clinical Microbiology and Infection. 2008;14:53-62. doi:10.1111/j.1469-0691.2007.01849.x.